CREA MEDIC
ActiveCREA MEDIC has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €11k and a net result of €157k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 7% of 16491 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
70
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency28=
Growth58=
Track record94
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €500 at 30 days acceptable
Liquidity tight (current ratio 1.03 against 1.03 in 2024; short-term debt: 97.3% and cash: 85.5% of total assets), and 97.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
2.7%
Return on assets
38.9%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 7% of 16491 sector peers (2025).
NBB · sector comparisonPosition among 16491 sector peers
Solvency
better than 7%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-03-2026, 129 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
129 d early
2024
147 d early
2023
128 d early
2022
81 d early
2021
25 d early
2020
25 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€11k▼ 0.6%
2024 · €11k
2020: €22k
2021: €95k
2022: €189k
2023: €1k
2024: €11k
2020 → 2025
Total assets
€403k▲ 9.4%
2024 · €369k
2020: €30k
2021: €106k
2022: €213k
2023: €278k
2024: €369k
2020 → 2025
Net result
€157k▼ 4.8%
2024 · €165k
2020: €22k
2021: €73k
2022: €95k
2023: €186k
2024: €165k
2020 → 2025
Working capital
€11k▲ 1.0%
2024 · €11k
2020: €22k
2021: €95k
2022: €187k
2023: €-534
2024: €11k
2020 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€95k-€189k▲ 99.8%€1k▼ 99.5%€11k▲ 990%€11k▼ 0.6%
Operating result€92k-€120k▲ 30.4%€246k▲ 105%€220k▼ 10.4%€210k▼ 4.7%
Net result€73k-€95k▲ 29.1%€186k▲ 97.0%€165k▼ 11.6%€157k▼ 4.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 5% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €403k
Equity
€11k▼ 0.6%
Debt
€392k▲ 9.7%
The debt ratio rises from 97.0% to 97.3%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€210k▼
2024 · €222k
Cash flow
€157k▼
2024 · €166k
Solvency
2.7%▼
2024 · 3.0%
Current ratio
1.03▼
2024 · 1.03
Quick ratio
1.03▼
2024 · 1.03
Debt / equity
36.21▲
2024 · 32.81
ROA
38.9%▼
2024 · 44.7%
Interest coverage
1657.65▼
2024 · 4327.74
Debt
€392k▲
2024 · €358k
Debt ≤ 1 year
€392k▲
2024 · €358k
Income taxes
€53k▼
2024 · €55k
A ratio outside any meaningful range has been withheld (balance sheet total €403k, equity €11k).
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€369k€403k▲
Fixed assets21/28€169€0▼
Tangible fixed assets22/27€169€0▼
Furniture and vehicles24€169€0▼
Current assets29/58€368k€403k▲
Amounts receivable within one year40/41€45k€53k▲
Trade receivables40€45k€46k▲
Other amounts receivable41-€7k
Cash at bank and in hand54/58€318k€345k▲
Deferred charges and accrued income490/1€5k€5k▲
Equity and liabilities
Total equity and liabilities10/49€369k€403k▲
Equity10/15€11k€11k▼
Contributions10/11€1k€1k=
Profit (loss) carried forward14€10k€10k▼
Amounts payable17/49€358k€392k▲
Amounts payable within one year42/48€358k€392k▲
Trade debts44€1k€356▼
Suppliers440/4€1k€356▼
Taxes, remuneration and social security45€63k€24k▼
Taxes450/3€63k€24k▼
Other amounts payable47/48€294k€368k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€169▼
Other operating charges640/8€387€0▼
Gross operating margin9900€222k€210k▼
Operating profit (loss)9901€220k€210k▼
Financial income75/76B€0€15▲
Recurring financial income75€0€15▲
Financial charges65/66B€51€127▲
Recurring financial charges65€51€127▲
Profit (loss) for the period before taxes9903€220k€210k▼
Income taxes67/77€55k€53k▼
Profit (loss) for the period9904€165k€157k▼
Profit (loss) for the period to be appropriated9905€165k€157k▼
Appropriation of the result
Profit (loss) to be appropriated9906€165k€167k▲
Profit (loss) brought forward from the previous period14P€0€10k▲
Profit to be distributed694/7€155k€157k▲
Return on contributions (dividend)694€155k€157k▲
The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
06-03
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
25-03
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Highest result since 2020net €186k ▲97%
Operating result €246k, net result €186k, both a record.
11-05
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Equity above €150kEq €189k ▲99.8%
3 profitable years in a row build equity to €189k.
06-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Liquidity doublescurrent ratio 9.70
Current ratio from 4.09 to 9.70.
25-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 25 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Gillis (bij-Brussel) · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Waterlose Steenweg 1571060 Sint-Gillis (bij-Brussel)Ground area
227 m²
Building footprint
128 m²
Volume, LiDAR
1,560 m³
Parcel 21562A0171/00R011, Brussels · tallest building 18.1 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
CREA MEDIC
since 20202.309.230.696
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21562A0171/00R011 | Brussels | 227 m² | 1 · 128 m² | 18.1 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
O2 CLINIC
BE 0804.100.009
Antwerpen · Eq €10k
AWADA CARDIO
BE 0722.813.910
Tervuren · Eq €19k
HEALTHCARE AND MEDICAL IMAGING SERVICE
BE 1010.011.312
Dilbeek · Eq €19k
CENTRE MEDICAL NUTRIESTHETIC
BE 0600.996.261
Liège · Eq €20k
B’YOU by Dr. Shèdy
BE 0778.916.433
Maasmechelen · Eq €5k
Of 105 companies in sector 86109 we hold annual accounts for 83. 22 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded20-10-2020
Fiscal year end31-12
Activities, NACEBEL
86109Human health activities
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:andreacarini1@gmail.com